Vanguard Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.11B Buy
23,483,741
+192,517
+0.8% +$18.3M 0.03% 471
2025
Q3
$2.29B Buy
23,291,224
+39,929
+0.2% +$3.96M 0.03% 445
2025
Q2
$2.12B Buy
23,251,295
+198,370
+0.9% +$19.2M 0.03% 450
2025
Q1
$2.61B Buy
23,052,925
+166,763
+0.7% +$17.8M 0.05% 384
2024
Q4
$2.42B Sell
22,886,162
-398,676
-2% -$42.8M 0.04% 411
2024
Q3
$2.51B Sell
23,284,838
-116,440
-0.5% -$12.7M 0.05% 401
2024
Q2
$2.54B Sell
23,401,278
-371,561
-2% -$43.8M 0.05% 368
2024
Q1
$3.14B Sell
23,772,839
-86,486
-0.4% -$10.8M 0.06% 321
2023
Q4
$2.9B Sell
23,859,325
-75,107
-0.3% -$8.38M 0.06% 315
2023
Q3
$2.69B Sell
23,934,432
-198,131
-0.8% -$25.2M 0.07% 309
2023
Q2
$3.51B Sell
24,132,563
-232,201
-1% -$31.6M 0.08% 239
2023
Q1
$3.15B Buy
24,364,764
+309,025
+1% +$38.8M 0.08% 265
2022
Q4
$3.07B Buy
24,055,739
+246,563
+1% +$28.6M 0.08% 261
2022
Q3
$2.49B Buy
23,809,176
+235,871
+1% +$25.9M 0.07% 288
2022
Q2
$2.48B Buy
23,573,305
+470,544
+2% +$55.8M 0.07% 293
2022
Q1
$2.95B Buy
23,102,761
+3,113,292
+16% +$375M 0.07% 292
2021
Q4
$2.47B Buy
19,989,469
+3,351,884
+20% +$439M 0.06% 370
2021
Q3
$2.36B Buy
16,637,585
+102,311
+0.6% +$15.1M 0.06% 354
2021
Q2
$2.58B Buy
16,535,274
+145,913
+0.9% +$23.6M 0.06% 328
2021
Q1
$2.55B Buy
16,389,361
+214,462
+1% +$33.2M 0.07% 311
2020
Q4
$2.42B Sell
16,174,899
-138,559
-0.8% -$19.6M 0.07% 301
2020
Q3
$2.16B Sell
16,313,458
-262,828
-2% -$34.3M 0.07% 288
2020
Q2
$1.92B Sell
16,576,286
-204,744
-1% -$23.6M 0.07% 304
2020
Q1
$1.65B Buy
16,781,030
+345,530
+2% +$45.3M 0.07% 284
2019
Q4
$2.39B Buy
16,435,500
+362,607
+2% +$50.1M 0.08% 256
2019
Q3
$2.14B Buy
16,072,893
+155,313
+1% +$20.1M 0.08% 267
2019
Q2
$1.82B Buy
15,917,580
+150,098
+1% +$17.6M 0.07% 314
2019
Q1
$1.95B Buy
15,767,482
+274,357
+2% +$31.2M 0.08% 274
2018
Q4
$1.56B Buy
15,493,125
+546,349
+4% +$61.4M 0.07% 303
2018
Q3
$1.91B Buy
14,946,776
+235,761
+2% +$28M 0.07% 269
2018
Q2
$1.59B Buy
14,711,015
+240,093
+2% +$26.1M 0.07% 330
2018
Q1
$1.53B Buy
14,470,922
+223,965
+2% +$26M 0.07% 338
2017
Q4
$1.67B Buy
14,246,957
+198,676
+1% +$22.5M 0.07% 310
2017
Q3
$1.6B Buy
14,048,281
+266,348
+2% +$30.7M 0.07% 294
2017
Q2
$1.72B Buy
13,781,933
+349,280
+3% +$41.4M 0.08% 255
2017
Q1
$1.59B Buy
13,432,653
+478,863
+4% +$54.3M 0.08% 273
2016
Q4
$1.3B Buy
12,953,790
+549,877
+4% +$58.9M 0.07% 305
2016
Q3
$1.57B Buy
12,403,913
+105,114
+0.9% +$13M 0.09% 236
2016
Q2
$1.44B Buy
12,298,799
+1,345,640
+12% +$152M 0.09% 243
2016
Q1
$1.13B Buy
10,953,159
+845,966
+8% +$81.8M 0.07% 300
2015
Q4
$1.01B Buy
10,107,193
+239,332
+2% +$23.4M 0.07% 313
2015
Q3
$900M Buy
9,867,861
+243,542
+3% +$24.4M 0.07% 330
2015
Q2
$1.02B Buy
9,624,319
+145,554
+2% +$16.1M 0.07% 313
2015
Q1
$1.08B Buy
9,478,765
+385,116
+4% +$43.9M 0.07% 296
2014
Q4
$1B Buy
9,093,649
+337,383
+4% +$35.6M 0.07% 300
2014
Q3
$855M Buy
8,756,266
+230,794
+3% +$22.7M 0.07% 322
2014
Q2
$860M Buy
8,525,472
+80,146
+0.9% +$7.82M 0.07% 320
2014
Q1
$775M Buy
8,445,326
+165,955
+2% +$15.3M 0.07% 327
2013
Q4
$749M Buy
8,279,371
+188,252
+2% +$16.3M 0.07% 326
2013
Q3
$645M Sell
8,091,119
-143,592
-2% -$11.3M 0.06% 344
2013
Q2
$599M Buy
+8,234,711
New +$616M 0.06% 349

Other funds holding ZBH